Aker Biomarine ASA
OSE:AKBM
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
22.1095
59.5148
|
Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Wall Street
Price Targets
AKBM Price Targets Summary
Aker Biomarine ASA
According to Wall Street analysts, the average 1-year price target for AKBM is 75.99 NOK with a low forecast of 70.7 NOK and a high forecast of 82.95 NOK.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is AKBM's stock price target?
Price Target
75.99
NOK
According to Wall Street analysts, the average 1-year price target for AKBM is 75.99 NOK with a low forecast of 70.7 NOK and a high forecast of 82.95 NOK.
What is Aker Biomarine ASA's Revenue forecast?
Projected CAGR
-5%
For the last 7 years the compound annual growth rate for Aker Biomarine ASA's revenue is 16%. The projected CAGR for the next 3 years is -5%.
What is Aker Biomarine ASA's Operating Income forecast?
Projected CAGR
207%
For the last 7 years the compound annual growth rate for Aker Biomarine ASA's operating income is -30%. The projected CAGR for the next 3 years is 207%.